BONDS/US761299AB20·USD·US·SENIOR UNSECUREDAS OF—

Travere Therapeutics Inc

Travere Therapeutics Inc 2.500% 2025/09 · matured

United States

Tune RadioSIMILAR

YIELD TO MATURITY

—

semi-annual

MID PRICE

—

par = 100

BOND INFO

What this bond is

terms · risk · identifiers

Coupon

2.500%

semi-annual · fixed

Maturity

2025/09

matured

Mod. duration

—

n/a for perpetuals

Convexity

—

n/a for perpetuals

Outstanding

—

not disclosed

Issued

—

not disclosed

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA

About the issuer

Martin Shkreli is an American investor and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.

Source: Wikipedia →

About this bond

AI BRIEF · LOADING

Identifiers

Security details

AWAITING ENRICHMENT

CUSIP

761299AB2

ISIN

US761299AB20

FACE

100 USD

SENIORITY

Senior Unsecured

BOND SIGNALS

What the market is saying

your fit · radio · footprint · upgrade for funds

For you

Your fit

Add positions to personalize — preview only

PREVIEW

Curve position

Rating cohort

Sector preference

Duration fit

Institutional footprint

Sherpa Signal

Thin coverage — below signal threshold

No institutional footprint detected yet. Signal emerges as the bond appears in tracked institutional portfolios.

PROUnlock the full signal tape, fund-level concentration, and the funds disclosing this bond.Upgrade

DISCOVERY

Travere Therapeutics Inc

What this bond is

About this bond

About this bond

Security details

What the market is saying

Your fit

Sherpa Signal

About this bond

Bonds like this